vimarsana.com

Latest Breaking News On - Global clinical trial - Page 3 : vimarsana.com

Covid-19, flu combo vaccines an advance but with distribution quandaries

Experts were less keen on variant-specific vaccines versus Covid-19/flu combo due to lack of practical value, despite scientific rationale.

United kingdomUnited statesBeta deltaAlpha deltaNovavax covidSanofi fluzoneJohn mccauleyNovavax nanofluWilliam schaffnerRodney rhodeReynold panettieri jrContract research organisation for clinical trialsVanderbilt universityUnited kingdom health security agencyFrancis crick instituteRutgers institute for translational medicine

Equillium begins Phase III acute graft-versus-host disease therapy trial

Equillium has commenced the Phase III EQUATOR clinical trial of itolizumab to treat acute graft-versus-host disease (aGVHD) patients.

Saas platform decentralizing clinical research at scaleEu open market solutions for clinical trialsMarket solutionsKey challengesGlobal clinical trial

Ukraine: Ex-FDAer calls for agency to stop Russian regulatory reviews

"I think it’s a terrible idea if the FDA would keep processing Russia entities’ pitches to enter the US market.”

Saint petersburgSankt peterburgPetrovax pharmJoe bidenTime data services for clinical researchSaint petersburg state universityOffice of orphan products developmentRadiologic healthStim cotClinical trialsClinical trials arenaDrugs evaluationBiologics evaluationOrphan productsOnly orphans cotTime data services

Maze Therapeutics initiates dosing in Phase I Pompe disease therapy trial

Maze has commenced participant dosing in its Phase I clinical trial of oral glycogen synthase (GYS1) inhibitor, MZE001, to treat Pompe diseas

Sarah noonbergLife sciences companiesTranslation services forMaze therapeuticsCellular immuneLife sciencesKey challengesGlobal clinical trial

Pardes reports interim data from Phase I trial of oral Covid-19 antiviral

Pardes Biosciences has reported interim results from the Phase I trial of its oral antiviral drug, PBI-0451, in healthy adult subjects.

New zealandPardes biosciencesDrug administrationParde investigational new drugPreference management solutionKey challengesGlobal clinical trial

vimarsana © 2020. All Rights Reserved.